InfraRdDx gets FDA clearance for LipiScan Coronary Imaging System

04/28/2008 | NYTimes.com

Federal regulators have cleared InfraRdDx's LipiScan Coronary Imaging System, a laser scanning device designed to detect fatty deposits in blood vessel walls. The product could help physicians when implanting stents in vessels, the company said.

View Full Article in:

NYTimes.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT